Diabetic cardiomyopathy: Does the type of diabetes matter?

International Journal of Molecular Sciences

Volumn 17, Issue 12, 2016, Pages

  Hölscher, Maximilian E ^a   Bode, Christoph ^a   Bugger, Heiko ^a  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

Diabetes mellitus; Diabetic cardiomyopathy; Heart

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); HEMOGLOBIN A1C; INSULIN; INSULIN RECEPTOR; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

APOPTOSIS; CAPILLARY DENSITY; CARDIAC MUSCLE; CLINICAL FEATURE; COLOR DOPPLER ECHOCARDIOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIABETIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; DISEASE REGISTRY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; REVIEW; SYSTOLIC DYSFUNCTION; COMPLICATION; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHIES; PATHOLOGY;

CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; HEART FAILURE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS;

EID: 85007240955     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17122136     Document Type: Review

References (57)

1. Kannel, W.B.; McGee, D.L. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241, 2035–2038.
2. Rubler, S.; Dlugash, J.; Yuceoglu, Y.Z.; Kumral, T.; Branwood, A.W.; Grishman, A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am. J. Cardiol. 1972, 30, 595–602.
3. Seferović, P.M.; Paulus, W.J. Clinical diabetic cardiomyopathy: A two-faced disease with restrictive and dilated phenotypes. Eur. Heart J. 2015, 36, 1718–1727.
4. Stratton, I.M.; Adler, A.I.; Neil, H.A.; Matthews, D.R.; Manley, S.E.; Cull, C.A.; Hadden, D.; Turner, R.C.; Holman, R.R. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000, 321, 405–412.
5. Nichols, G.A.; Gullion, C.M.; Koro, C.E.; Ephross, S.A.; Brown, J.B. The incidence of congestive heart failure in type 2 diabetes: An update. Diabetes Care 2004, 27, 1879–1884.
6. Iribarren, C.; Karter, A.J.; Go, A.S.; Ferrara, A.; Liu, J.Y.; Sidney, S.; Selby, J.V. Glycemic control and heart failure among adult patients with diabetes. Circulation 2001, 103, 2668–2673.
7. Kannel, W.B.; Hjortland, M.; Castelli, W.P. Role of diabetes in congestive heart failure: The Framingham study. Am. J. Cardiol. 1974, 34, 29–34.
8. Jaffe, A.S.; Spadaro, J.J.; Schechtman, K.; Roberts, R.; Geltman, E.M.; Sobel, B.E. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am. Heart J. 1984, 108, 31–37.
9. Iwasaka, T.; Takahashi, N.; Nakamura, S.; Sugiura, T.; Tarumi, N.; Kimura, Y.; Okubo, N.; Taniguchi, H.; Matsui, Y.; Inada, M. Residual left ventricular pump function after acute myocardial infarction in NIDDM patients. Diabetes Care 1992, 15, 1522–1526.
10. Eguchi, K.; Boden-Albala, B.; Jin, Z.; Rundek, T.; Sacco, R.L.; Homma, S.; di Tullio, M.R. Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population. Am. J. Cardiol. 2008, 101, 1787–1791.
11. Devereux, R.B.; Roman, M.J.; Paranicas, M.; O’Grady, M.J.; Lee, E.T.; Welty, T.K.; Fabsitz, R.R.; Robbins, D.; Rhoades, E.R.; Howard, B.V. Impact of diabetes on cardiac structure and function: The strong heart study. Circulation 2000, 101, 2271–2276.
12. Galderisi, M.; Anderson, K.M.; Wilson, P.W.; Levy, D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am. J. Cardiol. 1991, 68, 85–89.
13. Rutter, M.K.; Parise, H.; Benjamin, E.J.; Levy, D.; Larson, M.G.; Meigs, J.B.; Nesto, R.W.; Wilson, P.W.F.; Vasan, R.S. Impact of glucose intolerance and insulin resistance on cardiac structure and function: Sexrelated differences in the Framingham Heart Study. Circulation 2003, 107, 448–454.
14. Fontes-Carvalho, R.; Ladeiras-Lopes, R.; Bettencourt, P.; Leite-Moreira, A.; Azevedo, A. Diastolic dysfunction in the diabetic continuum: Association with insulin resistance, metabolic syndrome and type 2 diabetes. Cardiovasc. Diabetol. 2015, 14, 4.
15. Stahrenberg, R.; Edelmann, F.; Mende, M.; Kockskämper, A.; Düngen, H.D.; Scherer, M.; Kochen, M.M.; Binder, L.; Herrmann-Lingen, C.; Schönbrunn, L.; et al. Association of glucose metabolism with diastolic function along the diabetic continuum. Diabetologia 2010, 53, 1331–1340.
16. Zarich, S.W.; Arbuckle, B.E.; Cohen, L.R.; Roberts, M.; Nesto, R.W. Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. J. Am. Coll. Cardiol. 1988, 12, 114–120.
17. Bugger, H.; Abel, E.D. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 2014, 57, 660–671.
18. Yokoyama, I.; Momomura, S.; Ohtake, T.; Yonekura, K.; Nishikawa, J.; Sasaki, Y.; Omata, M. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 1997, 30, 1472–1477.
19. Picchi, A. Coronary microvascular dysfunction in diabetes mellitus: A review. World J. Cardiol. 2010, 2, 377.
20. Kawata, T.; Daimon, M.; Miyazaki, S.; Ichikawa, R.; Maruyama, M.; Chiang, S.-J.; Ito, C.; Sato, F.; Watada, H.; Daida, H. Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus. Cardiovasc. Diabetol. 2015, 14, 98.
21. Brunvand, L.; Fugelseth, D.; Stensaeth, K.H.; Dahl-Jørgensen, K.; Margeirsdottir, H.D. Early reduced myocardial diastolic function in children and adolescents with type 1 diabetes mellitus a population-based study. BMC Cardiovasc. Disord. 2016, 16, 103.
22. Lind, M.; Bounias, I.; Olsson, M.; Gudbjörnsdottir, S.; Svensson, A.-M.; Rosengren, A. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: An observational study. Lancet Lond. Engl. 2011, 378, 140–146.
23. Wilhelmsen, L.; Rosengren, A.; Eriksson, H.; Lappas, G. Heart failure in the general population of men—Morbidity, risk factors and prognosis. J. Intern. Med. 2001, 249, 253–261.
24. Rosengren, A.; Vestberg, D.; Svensson, A.-M.; Kosiborod, M.; Clements, M.; Rawshani, A.; Pivodic, A.; Gudbjörnsdottir, S.; Lind, M. Long-term excess risk of heart failure in people with type 1 diabetes: A prospective case-control study. Lancet Diabetes Endocrinol. 2015, 3, 876–885.
25. Konduracka, E.; Cieslik, G.; Galicka-Latala, D.; Rostoff, P.; Pietrucha, A.; Latacz, P.; Gajos, G.; Malecki, M.T.; Nessler, J. Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: A 7-year prospective cohort study. Acta Diabetol. 2013, 50, 597–606.
26. Raev, D.C. Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients. Diabetes Care 1994, 17, 633–639.
27. Berková, M.; Opavský, J.; Berka, Z.; Skranka, V.; Salinger, J. Left ventricular diastolic filling in young persons with type 1 diabetes mellitus. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czechoslov. 2003, 147, 57–61.
28. Schannwell, C.M.; Schneppenheim, M.; Perings, S.; Plehn, G.; Strauer, B.E. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 2002, 98, 33–39.
29. Christiansen, E.H.; Mølgaard, H.; Christensen, P.D.; Sørensen, K.E.; Christensen, C.K.; Mogensen, C.E. Increased left ventricular systolic function in insulin dependent diabetic patients with normal albumin excretion. Eur. Heart J. 1998, 19, 1735–1739.
30. Di Cori, A.; di Bello, V.; Miccoli, R.; Talini, E.; Palagi, C.; Delle Donne, M.G.; Penno, G.; Nardi, C.; Bianchi, C.; Mariani, M.; et al. Left ventricular function in normotensive young adults with well-controlled type 1 diabetes mellitus. Am. J. Cardiol. 2007, 99, 84–90.
31. Labombarda, F.; Leport, M.; Morello, R.; Ribault, V.; Kauffman, D.; Brouard, J.; Pellissier, A.; Maragnes, P.; Manrique, A.; Milliez, P.; et al. Longitudinal left ventricular strain impairment in type 1 diabetes children and adolescents: A 2D speckle strain imaging study. Diabetes Metab. 2014, 40, 292–298.
32. Scognamiglio, R.; Avogaro, A.; Casara, D.; Crepaldi, C.; Marin, M.; Palisi, M.; Mingardi, R.; Erle, G.; Fasoli, G.; Dalla Volta, S. Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 1998, 31, 404–412.
33. Vered, A.; Battler, A.; Segal, P.; Liberman, D.; Yerushalmi, Y.; Berezin, M.; Neufeld, H.N. Exercise-induced left ventricular dysfunction in young men with asymptomatic diabetes mellitus (diabetic cardiomyopathy). Am. J. Cardiol. 1984, 54, 633–637.
34. Romanens, M.; Fankhauser, S.; Saner, B.; Michaud, L.; Saner, H. No evidence for systolic or diastolic left ventricular dysfunction at rest in selected patients with long-term type I diabetes mellitus. Eur. J. Heart Fail. 1999, 1, 169–175.
35. Litwin, S.E. Diabetes and the heart: Is there objective evidence of a human diabetic cardiomyopathy? Diabetes 2013, 62, 3329–3330.
36. Bugger, H.; Abel, E.D. Rodent models of diabetic cardiomyopathy. Dis. Model. Mech. 2009, 2, 454–466.
37. Ishibashi, S.; Goldstein, J.L.; Brown, M.S.; Herz, J.; Burns, D.K. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Investig. 1994, 93, 1885–1893.
38. Cheng, Y.; Ji, R.; Yue, J.; Yang, J.; Liu, X.; Chen, H.; Dean, D.B.; Zhang, C. MicroRNAs are aberrantly expressed in hypertrophic heart: Do they play a role in cardiac hypertrophy? Am. J. Pathol. 2007, 170, 1831–1840.
39. 4 mice. Am. J. Physiol. Heart Circ. Physiol. 2002, 283, H976–H982.
40. Stuckey, D.J.; Carr, C.A.; Tyler, D.J.; Aasum, E.; Clarke, K. Novel MRI method to detect altered left ventricular ejection and filling patterns in rodent models of disease. Magn. Reson. Med. 2008, 60, 582–587.
41. Mazumder, P.K.; O’Neill, B.T.; Roberts, M.W.; Buchanan, J.; Yun, U.J.; Cooksey, R.C.; Boudina, S.; Abel, E.D. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 2004, 53, 2366–2374.
42. Buchanan, J.; Mazumder, P.K.; Hu, P.; Chakrabarti, G.; Roberts, M.W.; Yun, U.J.; Cooksey, R.C.; Litwin, S.E.; Abel, E.D. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 2005, 146, 5341–5349.
43. Zlobine, I.; Gopal, K.; Ussher, J.R. Lipotoxicity in obesity and diabetes-related cardiac dysfunction. Biochim. Biophys. Acta 2016, 1861, 1555–1568.
44. Belke, D.D.; Betuing, S.; Tuttle, M.J.; Graveleau, C.; Young, M.E.; Pham, M.; Zhang, D.; Cooksey, R.C.; McClain, D.A.; Litwin, S.E.; et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J. Clin. Investig. 2002, 109, 629–639.
45. Abel, E.D.; O’Shea, K.M.; Ramasamy, R. Insulin resistance: Metabolic mechanisms and consequences in the heart. Arterioscler. Thromb. Vasc. Biol. 2012, 32, 2068–2076.
46. Kajstura, J.; Fiordaliso, F.; Andreoli, A.M.; Li, B.; Chimenti, S.; Medow, M.S.; Limana, F.; Nadal-Ginard, B.; Leri, A.; Anversa, P. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 2001, 50, 1414–1424.
47. Lacombe, V.A.; Viatchenko-Karpinski, S.; Terentyev, D.; Sridhar, A.; Emani, S.; Bonagura, J.D.; Feldman, D.S.; Györke, S.; Carnes, C.A. Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293, R1787–R1797.
48. Basu, R.; Thimmaiah, T.G.; Chawla, J.M.; Schlicht, P.; Fagiolini, A.; Brar, J.S.; Khan, S.A.; Challa, A.; Chengappa, K.N.R. Changes in metabolic syndrome parameters in patients with schizoaffective disorder who participated in a randomized, placebo-controlled trial of topiramate. Asian J. Psychiatry 2009, 2, 106–111.
49. Nielsen, L.B.; Bartels, E.D.; Bollano, E. Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J. Biol. Chem. 2002, 277, 27014–27020.
50. Joubert, M.; Bellevre, D.; Legallois, D.; Elie, N.; Coulbault, L.; Allouche, S.; Manrique, A. Hyperglycemiainduced hypovolemia is involved in early cardiac magnetic resonance alterations in streptozotocin-induced diabetic mice: A comparison with furosemide-induced hypovolemia. PLoS ONE 2016, 11, e0149808.
51. Liang, Q.; Carlson, E.C.; Donthi, R.V.; Kralik, P.M.; Shen, X.; Epstein, P.N. Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 2002, 51, 174–181.
52. Ye, G.; Metreveli, N.S.; Ren, J.; Epstein, P.N. Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes 2003, 52, 777–783.
53. 4/NF-κB pathway. Am. J. Physiol. Heart Circ. Physiol. 2012, 303, H353–H367.
54. Bugger, H.; Boudina, S.; Hu, X.X.; Tuinei, J.; Zaha, V.G.; Theobald, H.A.; Yun, U.J.; McQueen, A.P.; Wayment, B.; Litwin, S.E.; et al. Type 1 diabetic Akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3. Diabetes 2008, 57, 2924–2932.
55. Bugger, H.; Riehle, C.; Jaishy, B.; Wende, A.R.; Tuinei, J.; Chen, D.; Soto, J.; Pires, K.M.; Boudina, S.; Theobald, H.A.; et al. Genetic loss of insulin receptors worsens cardiac efficiency in diabetes. J. Mol. Cell. Cardiol. 2012, 52, 1019–1026.
56. Bolzán, A.D.; Bianchi, M.S. Genotoxicity of streptozotocin. Mutat. Res. 2002, 512, 121–134.
57. Lashin, O.M.; Szweda, P.A.; Szweda, L.I.; Romani, A.M.P. Decreased complex II respiration and HNE-modified SDH subunit in diabetic heart. Free Radic. Biol. Med. 2006, 40, 886–896.